A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.
A new trial at Sheffield Children's Hospital will test whether a combined inhaler can better control asthma symptoms and attacks in youngsters. The study, which focuses on children aged six to 11, ...
More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.
MEMPHIS, Tenn. - Rates of childhood asthma cases are higher in the Mid-South than in most other parts of the country, but it's becoming harder for parents to get the medication their child needs.
Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...
A NEW technology that encourages child asthmatics to take medications has been hailed by experts as a breakthrough device, after a landmark study, showed children were 180% more likely to comply with ...
Regarding who can use these inhalers, NHS guidelines state: "Most adults can use beclometasone inhalers for asthma or COPD.
For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...
More children stopped using steroid inhalers to control their asthma after GlaxoSmithKline withdrew Flovent from the market. Adobe stock/HealthDay More children stopped using steroid inhalers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results